These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32948398)

  • 41. Gastroparesis: what is the current state-of-the-art for evaluation and medical management? What are the results?
    Lee A
    J Gastrointest Surg; 2013 Sep; 17(9):1553-6. PubMed ID: 23801519
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Diabetic gastroenteropathy: modern methods of diagnosis and treatment].
    Kuznetsov KO; Mikheeva AJ; Ishmukhametova AA; Tolstykh TA; Gallyametdinova AR; Botirova ZU; Zabirova AA; Sharipova AS; Shaikhlislamova AB; Abdrakhmanova DR
    Probl Endokrinol (Mosk); 2022 Jul; 68(5):67-78. PubMed ID: 36337020
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heme oxygenase-1 protects interstitial cells of Cajal from oxidative stress and reverses diabetic gastroparesis.
    Choi KM; Gibbons SJ; Nguyen TV; Stoltz GJ; Lurken MS; Ordog T; Szurszewski JH; Farrugia G
    Gastroenterology; 2008 Dec; 135(6):2055-64, 2064.e1-2. PubMed ID: 18926825
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacological Approaches to Diabetic Gastroparesis: A systematic review of randomised clinical trials.
    Asha MZ; Khalil SFH
    Sultan Qaboos Univ Med J; 2019 Nov; 19(4):e291-e304. PubMed ID: 31897312
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histologic changes in diabetic gastroparesis.
    Farrugia G
    Gastroenterol Clin North Am; 2015 Mar; 44(1):31-8. PubMed ID: 25667021
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abnormal ghrelin and pancreatic polypeptide responses in gastroparesis.
    Gaddipati KV; Simonian HP; Kresge KM; Boden GH; Parkman HP
    Dig Dis Sci; 2006 Aug; 51(8):1339-46. PubMed ID: 16868831
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Atractylenolide‑1 alleviates gastroparesis in diabetic rats by activating the stem cell factor/c‑kit signaling pathway.
    Li H; Cao W; Zhang XB; Zhang XX; Gu C; Gu LM; Pan CY; Tian YZ; Lu M
    Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34368880
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study.
    Murray CD; Martin NM; Patterson M; Taylor SA; Ghatei MA; Kamm MA; Johnston C; Bloom SR; Emmanuel AV
    Gut; 2005 Dec; 54(12):1693-8. PubMed ID: 16085693
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of cisapride on gastric emptying of indigestible solids in patients with gastroparesis diabeticorum. A comparison with metoclopramide and placebo.
    Feldman M; Smith HJ
    Gastroenterology; 1987 Jan; 92(1):171-4. PubMed ID: 3781184
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of diabetic gastroparesis.
    Mukhopadhyay P; Basu AK
    J Indian Med Assoc; 2005 Mar; 103(3):184, 186. PubMed ID: 16173296
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of patients with diabetic gastroparesis.
    Parkman HP; Fass R; Foxx-Orenstein AE
    Gastroenterol Hepatol (N Y); 2010 Jun; 6(6):1-16. PubMed ID: 20733935
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New developments in the treatment of gastroparesis and functional dyspepsia.
    Tack J; Camilleri M
    Curr Opin Pharmacol; 2018 Dec; 43():111-117. PubMed ID: 30245474
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomized clinical trial: a controlled pilot trial of the 5-HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis.
    Tack J; Rotondo A; Meulemans A; Thielemans L; Cools M
    Neurogastroenterol Motil; 2016 Apr; 28(4):487-97. PubMed ID: 27010235
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gastroparesis: a turning point in understanding and treatment.
    Grover M; Farrugia G; Stanghellini V
    Gut; 2019 Dec; 68(12):2238-2250. PubMed ID: 31563877
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Review article: The diagnosis and management of gastroparesis.
    Haans JJ; Masclee AA
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():37-46. PubMed ID: 18081647
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ghrelin receptor agonists: a new class of prokinetic agents.
    Neurogastroenterol Motil; 2010 Oct; 22(10):1043-4. PubMed ID: 20840719
    [No Abstract]   [Full Text] [Related]  

  • 57. Diabetic gastroparesis.
    Vanormelingen C; Tack J; Andrews CN
    Br Med Bull; 2013; 105():213-30. PubMed ID: 23363458
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gastric motor effects of ghrelin and growth hormone releasing peptide 6 in diabetic mice with gastroparesis.
    Qiu WC; Wang ZG; Wang WG; Yan J; Zheng Q
    World J Gastroenterol; 2008 Mar; 14(9):1419-24. PubMed ID: 18322959
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glucose sensor-augmented continuous subcutaneous insulin infusion in patients with diabetic gastroparesis: An open-label pilot prospective study.
    Calles-Escandón J; Koch KL; Hasler WL; Van Natta ML; Pasricha PJ; Tonascia J; Parkman HP; Hamilton F; Herman WH; Basina M; Buckingham B; Earle K; Kirkeby K; Hairston K; Bright T; Rothberg AE; Kraftson AT; Siraj ES; Subauste A; Lee LA; Abell TL; McCallum RW; Sarosiek I; Nguyen L; Fass R; Snape WJ; Vaughn IA; Miriel LA; Farrugia G;
    PLoS One; 2018; 13(4):e0194759. PubMed ID: 29652893
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emerging treatments in Neurogastroenterology: relamorelin: a novel gastrocolokinetic synthetic ghrelin agonist.
    Camilleri M; Acosta A
    Neurogastroenterol Motil; 2015 Mar; 27(3):324-32. PubMed ID: 25545036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.